Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 2;51(9):afac189.
doi: 10.1093/ageing/afac189.

Psychotropic drug treatment for agitated behaviour in dementia: what if the guideline prescribing recommendations are not sufficient? A qualitative study

Margaretha T Dijk  1   2 , Sarah Tabak  1 , Cees M P M Hertogh  1   2 , Rob M Kok  3 , Rob J van Marum  1   2   4 , Sytse U Zuidema  5 , Eefje M Sizoo  1   2 , Martin Smalbrugge  1   2
Affiliations

Psychotropic drug treatment for agitated behaviour in dementia: what if the guideline prescribing recommendations are not sufficient? A qualitative study

Margaretha T Dijk et al. Age Ageing. .

Abstract

Background: Agitation is a common challenging behaviour in dementia with a negative influence on patient's quality of life and a high caregiver burden. Treatment is often difficult. Current guidelines recommend restrictive use of psychotropic drug treatment, but guideline recommendations do not always suffice.

Objective: To explore how physicians decide on psychotropic drug treatment for agitated behaviour in dementia when the guideline prescribing recommendations are not sufficient.

Methods: We conducted five online focus groups with a total of 22 elderly care physicians, five geriatricians and four old-age psychiatrists, in The Netherlands. The focus groups were thematically analysed.

Results: We identified five main themes. Transcending these themes, in each of the focus groups physicians stated that there is 'not one size that fits all'. The five themes reflect physicians' considerations when deciding on psychotropic drug treatment outside the guideline prescribing recommendations for agitated behaviour in dementia: (1) 'reanalysis of problem and cause', (2) 'hypothesis of underlying cause and treatment goal', (3) 'considerations regarding drug choice', (4) 'trial and error' and (5) 'last resort: sedation'.

Conclusion: When guideline prescribing recommendations do not suffice, physicians start with reanalysing potential underlying causes. They try to substantiate and justify medication choices as best as they can with a hypothesis of underlying causes or treatment goal, using other guidelines, and applying personalised psychotropic drug treatment.

Keywords: agitated behaviour in dementia; decision making; focus group; non-guideline treatment; older people; psychotropic drugs; qualitative.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Code tree of main themes and their interrelation.
See this image and copyright information in PMC

References

    1. Zuidema SU, Derksen E, Verhey FR, Koopmans RT. Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia. Int J Geriatr Psychiatry 2007; 22: 632–8. - PubMed
    1. Wetzels RB, Zuidema SU, Jonghe JF, Verhey FR, Koopmans RT. Course of neuropsychiatric symptoms in residents with dementia in nursing homes over 2-year period. Am J Geriatr Psychiatry 2010; 18: 1054–65. - PubMed
    1. Borsje P, Lucassen P, Wetzels RB, Pot AM, Koopmans R. Neuropsychiatric symptoms and psychotropic drug use in patients with dementia in general practices. Fam Pract 2018; 35: 22–8. - PubMed
    1. Khoo SA, Chen TY, Ang YH, Yap P. The impact of neuropsychiatric symptoms on caregiver distress and quality of life in persons with dementia in an Asian tertiary hospital memory clinic. Int Psychogeriatr 2013; 25: 1991–9. - PubMed
    1. Zuidema SU, Smalbrugge M, Bil WMEet al. . Multidisciplinary Guideline problem behaviour in dementia. Verenso: NIP. Utrecht, 2018.

Publication types

Substances